How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market access. 01022024160129
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Executive Insights Diagnostics, Tools and Personalized Medicine Commercial Excellence in Life Sciences Tools and Services Companies April 8, 2024
Video / Webinar Life Sciences & Pharma L.E.K. Look Forward - L.E.K. Talent Focused Organisational Strategy December 13, 2023
